/SSKN
SSKN Stock - STRATA Skin Sciences, Inc.
Healthcare|Medical - DevicesNASDAQ
$1.19-3.25%
$0.04 (-3.25%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.31
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SSKN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.18 – $1.20
TARGET (TP)$1.37
STOP LOSS$1.09
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.26
52W High$3.86
52W Low$1.19
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $33.56M | $33.36M | $36.16M | $29.98M | $23.09M |
| Gross Profit | $19.08M | $18.46M | $21.77M | $19.85M | $14.13M |
| Gross Margin | 56.9% | 55.3% | 60.2% | 66.2% | 61.2% |
| Operating Income | $-9,255,000 | $-8,604,000 | $-4,649,000 | $-4,402,000 | $-4,076,000 |
| Net Income | $-10,086,000 | $-10,830,000 | $-5,549,000 | $-2,706,000 | $-4,412,000 |
| Net Margin | -30.1% | -32.5% | -15.3% | -9.0% | -19.1% |
| EPS | $-0.26 | $-0.31 | $-0.16 | $-0.08 | $-0.13 |
Company Overview
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SSKNBeat Rate
32%
Last 19 quarters
Avg Surprise
-256.4%
EPS vs Estimate
Beats / Misses
6/13
Last 12 quarters
Latest EPS
$-0.36
Q4 2025
EPS Surprise History
Q1 24
-450.0%
$-0.40vs$-0.07
Q2 24
-1328.6%
$-1.00vs$-0.07
Q3 24
+95.7%
$-0.03vs$-0.70
Q4 24
-20.5%
$-0.53vs$-0.44
Q1 25
-276.7%
$-1.13vs$-0.30
Q2 25
-11.5%
$-0.58vs$-0.52
Q3 25
-150.0%
$-0.60vs$-0.24
Q4 25
-38.5%
$-0.36vs$-0.26
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 26, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | $-0.26 | $-0.36 | -38.5% | ✗ MISS |
Q3 2025 | Aug 13, 2025 | $-0.24 | $-0.60 | -150.0% | ✗ MISS |
Q2 2025 | May 14, 2025 | $-0.52 | $-0.58 | -11.5% | ✗ MISS |
Q1 2025 | Mar 27, 2025 | $-0.30 | $-1.13 | -276.7% | ✗ MISS |
Q4 2024 | Nov 13, 2024 | $-0.44 | $-0.53 | -20.5% | ✗ MISS |
Q3 2024 | Aug 14, 2024 | $-0.70 | $-0.03 | +95.7% | ✓ BEAT |
Q2 2024 | May 15, 2024 | $-0.07 | $-1.00 | -1328.6% | ✗ MISS |
Q1 2024 | Mar 27, 2024 | $-0.07 | $-0.40 | -450.0% | ✗ MISS |
Q4 2023 | Nov 14, 2023 | $-0.24 | $-0.30 | -25.0% | ✗ MISS |
Q3 2023 | Aug 9, 2023 | $-0.05 | $-0.90 | -1700.0% | ✗ MISS |
Q2 2023 | May 15, 2023 | $-0.07 | $-0.80 | -1042.9% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-0.05 | $-0.00 | +90.8% | ✓ BEAT |
Q4 2022 | Nov 9, 2022 | $-0.60 | $-0.30 | +50.0% | ✓ BEAT |
Q3 2022 | Aug 10, 2022 | $-0.40 | $-0.50 | -25.0% | ✗ MISS |
Q2 2022 | May 11, 2022 | $-0.50 | $-0.70 | -40.0% | ✗ MISS |
Q1 2022 | Mar 21, 2022 | $-0.30 | $-0.20 | +33.3% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $-0.40 | $-0.20 | +50.0% | ✓ BEAT |
Q3 2021 | Aug 16, 2021 | $-0.60 | $-0.30 | +50.0% | ✓ BEAT |
Q2 2021 | May 12, 2021 | $-0.30 | $-0.70 | -133.3% | ✗ MISS |
Latest News
Strata Skin Sciences Q3 EPS $(0.36) Beats $(0.39) Estimate, Sales $6.929M Miss $8.226M Estimate
➖ NeutralBenzinga•Nov 13, 2025, 09:06 PM
STRATA Skin Sciences' TheraClearX Treatment For Acne Gets Regulatory Approval From Mexico's Health Authority Through November 2029
📈 PositiveBenzinga•Oct 28, 2025, 12:09 PM
STRATA Skin Sciences Announces That The U.S. District Court For The Eastern District Of Pennsylvania Expanded Its Injunction In STRATA's Favor Against LaserOptek And Its Affiliates, Prohibiting Them From Falsely Marketing Pallas Laser Systems As Reimbursable And From Making Misleading Claims About Strata's Products
📈 PositiveBenzinga•Oct 20, 2025, 12:11 PM
STRATA Skin Sciences shares are trading higher. The company published clinical case study showing resolution of lesions with 308-Nm Excimer laser in rare mycosis fungoides subtype, poikilodermatous mycosis fungiodes.
📈 PositiveBenzinga•Oct 14, 2025, 06:12 PM
STRATA Skin Sciences Publishes Clinical Case Study On 308-Nm Excimer Laser Use In Rare pMF Subtype Of Cutaneous T-Cell Lymphoma
➖ NeutralBenzinga•Oct 14, 2025, 12:24 PM
STRATA Skin Sciences Highlights Clinical Evidence Supporting XTRAC Excimer Laser In Atopic Dermatitis As AMA Expansion Unlocks Medicare, Medicaid, And Private Payer Reimbursement Path
📈 PositiveBenzinga•Oct 3, 2025, 02:59 PM
Strata Skin's Treatment For Plaque-Type Psoriasis Enhances Outcomes Compared To Topical Monotherapy, Study Demonstrates
📈 PositiveBenzinga•Sep 30, 2025, 12:21 PM
STRATA Skin Sciences Highlights Peer-Reviewed Study Showing Superior Efficacy Of 308nm Excimer Laser In Combination With Oral JAK Inhibitor In Vitiligo Treatment
📈 PositiveBenzinga•Sep 22, 2025, 12:22 PM
STRATA Skin Sciences Reports Growth In Partner Clinics Using Elevate 360 Platform
📈 PositiveBenzinga•Sep 4, 2025, 12:28 PM
Strata Skin Sciences shares are trading lower after the company announced the pricing of a $2.42 million offering of 1,097,547 shares at $2.204 per share.
📉 NegativeBenzinga•Sep 3, 2025, 01:05 PM
STRATA Skin Sciences announces $2.42M registered direct offering; shares down
📉 NegativeSeeking Alpha•Sep 3, 2025, 12:24 PM
Strata Skin Sciences Prices $2.42M Offering Of 1,097,547 Shares At $2.204/Share
➖ NeutralBenzinga•Sep 3, 2025, 12:07 PM
Strata Skin Sciences shares are trading higher after the company announced that its patent portfolio provides intellectual property and market exclusivity for combination therapies of its XTRAC excimer laser when used with JAK inhibitor
📈 PositiveBenzinga•Sep 2, 2025, 01:26 PM
STRATA Skin Sciences Says Its Patent Portfolio Provides IP And Market Exclusivity For Combination Therapies Of Its XTRAC Excimer Laser With JAK Inhibitors
📈 PositiveBenzinga•Sep 2, 2025, 12:09 PM
Strata Skin Sciences Sales Decline
📉 NegativeThe Motley Fool•Aug 13, 2025, 10:36 PM
STRATA Skin Sciences Eyes Market Growth
📈 PositiveThe Motley Fool•Aug 13, 2025, 09:53 PM
Frequently Asked Questions about SSKN
What is SSKN's current stock price?
STRATA Skin Sciences, Inc. (SSKN) is currently trading at $1.19 per share. The stock has moved -3.25% today.
What is the analyst price target for SSKN?
No analyst price targets are currently available for this stock.
What sector is STRATA Skin Sciences, Inc. in?
STRATA Skin Sciences, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is SSKN's market cap?
STRATA Skin Sciences, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does SSKN pay dividends?
No, STRATA Skin Sciences, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADIL
Adial Pharmaceuticals, Inc.
$0.24
Mkt Cap: $0.0B
ADXN
Addex Therapeutics Ltd
$7.83
Mkt Cap: $0.0B
BCLI
Brainstorm Cell Therapeutics Inc.
$0.56
Mkt Cap: $0.0B
BMRA
Biomerica, Inc.
$2.31
Mkt Cap: $0.0B
GBS
GBS Inc.
$0.47
Mkt Cap: $0.0B
HSCS
HeartSciences Inc.
$2.36
Mkt Cap: $0.0B
IINN
Inspira Technologies Oxy B.H.N. Ltd.
$1.02
Mkt Cap: $0.0B
MHUA
Meihua International Medical Technologies Co., Ltd.
$7.09
Mkt Cap: $0.0B
NRSN
NeuroSense Therapeutics Ltd.
$0.81
Mkt Cap: $0.0B
PAVM
PAVmed Inc.
$0.31
Mkt Cap: $0.0B
Explore stocks similar to SSKN for comparison